JULIE PAUL: Open Payments
NPI 1235533837 · NEW LENOX, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$984 in 48 payments from 17 companies in 2025. Trend: 2023 $816 · 2024 $690 · 2025 $984
Food & beverage: $984
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 9 | $181 |
| Organon LLC | 5 | $124 |
| Astellas Pharma US Inc | 5 | $95 |
| MILLICENT US INC | 5 | $92 |
| Biogen, Inc. | 4 | $70 |
| Exeltis, USA Inc. | 4 | $66 |
| Phathom Pharmaceuticals, Inc. | 1 | $55 |
| Sumitomo Pharma America, Inc. | 2 | $47 |
| Hologic Sales and Service, LLC | 2 | $41 |
| ABBVIE INC. | 2 | $37 |
Products named: Veozah, NEXPLANON, ZURZUVAE, SLYND, FEMLYV, VOQUEZNA, MYFEMBREE, Sonata Sonography-Guided Transcervical Fibroid Ablation System.
Industry payments across IL — which companies pay providers there.
